Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Kriya Announces $270M Series C Financing

2022-05-17
REDWOOD CITY, CA, Kriya Therapeutics, a gene therapy company, announced a $270 Million Series C financing.
REDWOOD CITY, CA, Kriya Therapeutics, a fully integrated gene therapy company pioneering novel technologies and therapeutics, announced a $270 Million Series C financing.

The financing was led by Patient Square Capital, with participation from Bluebird Ventures, CAM Capital, Dexcel Pharma, Foresite Capital, JDRF T1D Fund, Lightswitch Capital, Narya Capital, QVT, Transhuman Capital, and other undisclosed investors.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors